This study assesses the clinical and economic implications from a payer perspective of human papillomavirus genotyping for cervical cancer screening in comparison with existing practices.
Joice Huang, PharmD, MBA
Advertisement
Articles by Joice Huang, PharmD, MBA
Advertisement
Latest Updated Articles
- The Budget Impact of Cervical Cancer Screening Using HPV Primary Screening
Published: March 1st 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
2
CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts
3
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
4
Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma
5
